Abstract | AIMS: METHODS: A total of 634 patients with endoscopically confirmed GERD grade 0/I and heartburn were included. During the acute phase, patients were treated with pantoprazole 20 mg once daily for 4 weeks. Those patients relieved from heartburn entered the long-term phase, and were randomly assigned to either treatment group pantoprazole 20 mg, 40 mg or placebo. Over 6 months, patients took study medication on demand ( antacids as rescue medication) and discontinued the drug once symptoms abated. RESULTS: After 4 weeks a total of 87.1%/90.0% of patients were free of heartburn (ITT/PP), and entered the subsequent long-term phase. The perceived average daily symptom load (placebo: 3.93, pantoprazole 20 mg: 2.91, pantoprazole 40 mg: 2.71, ITT) and the number of antacid tablets taken (average number, placebo: 0.68, pantoprazole 20 mg: 0.45, pantoprazole 40 mg: 0.33, ITT) were significantly higher in the placebo than in both pantoprazole groups (p<0.0001), with no statistically significant difference between the two pantoprazole groups. The discontinuation rate due to insufficient control of heartburn was significantly lower in both pantoprazole groups compared to placebo (placebo: 10.9, pantoprazole 20 mg: 2.8, pantoprazole 40 mg: 0.9, ITT). CONCLUSIONS: Our findings favor on-demand treatment with pantoprazole 20 mg for the long-term management of heartburn in patients with uncomplicated GERD (grade 0/I) with superiority to placebo.
|
Authors | T Scholten, C P M Dekkers, K Schütze, T Körner, M Bohuschke, G Gatz |
Journal | Digestion
(Digestion)
Vol. 72
Issue 2-3
Pg. 76-85
( 2005)
ISSN: 0012-2823 [Print] Switzerland |
PMID | 16113546
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright (c) 2005 S. Karger AG, Basel. |
Chemical References |
- 2-Pyridinylmethylsulfinylbenzimidazoles
- Antacids
- Anti-Ulcer Agents
- Benzimidazoles
- Sulfoxides
- Pantoprazole
- Omeprazole
|
Topics |
- 2-Pyridinylmethylsulfinylbenzimidazoles
- Antacids
(therapeutic use)
- Anti-Ulcer Agents
(administration & dosage, therapeutic use)
- Benzimidazoles
(administration & dosage, therapeutic use)
- Female
- Gastroesophageal Reflux
(drug therapy)
- Humans
- Male
- Middle Aged
- Omeprazole
(administration & dosage, analogs & derivatives, therapeutic use)
- Pantoprazole
- Statistics, Nonparametric
- Sulfoxides
(administration & dosage, therapeutic use)
- Treatment Outcome
|